IGM BIOSCIENCES APPOINTS MISBAH TAHIR AS CHIEF FINANCIAL OFFICER
MOUNTAIN VIEW, Calif., Jan. 3, 2019 /PRNewswire/ — IGM Biosciences, Inc. (IGM), a privately held biotechnology company and a global leader in the research and development of therapeutic IgM antibodies, today announced the appointment of Misbah Tahir to the newly created position of Chief Financial Officer. Mr. Tahir joins IGM with more than twenty years of experience in finance and strategic planning, including public market financings and product launches. Most recently, Mr. Tahir was Vice President, Head of Finance at Dermira, Inc., where he helped build the finance, treasury, accounting and SEC compliance and reporting functions during a period of rapid growth, and played an integral role in the company’s initial public offering and follow-on public financings. Read the full release
